Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Trial on the Use of ARA 290 for the Treatment of Diabetic Macular Oedema

NCT06626971 is registered in ClinicalTrials.gov with Belfast Health and Social Care Trust as lead sponsor.

NCT NCT06626971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06626971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Trial on the Use of ARA 290 for the Treatment of Diabetic Macular Oedema
Lead sponsor
Belfast Health and Social Care Trust
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2016
Completion date
August 31, 2017
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular oedema